JBM  Vol.7 No.12 , December 2019
The Application Prospect Autologous Bone Marrow Extract Buffy Coat in Cartilage Tissue Engineering: A Mini-Review
Abstract: Cartilage injury is an important cause of osteoarthritis; however, there is no effective method of cartilage regeneration at present. Therefore, it would be of great value to explore and develop new methods of cartilage regeneration. In recent years, it has become a hot topic on repairing damaged cartilage by using tissue engineered cartilage domestic and abroad. It’s the key factor to success for getting cell source which is effective, applicable and easy to obtain in the technology of cartilage tissue engineering filed. This article summarizes the research progress of bone marrow extract buffy coat in cartilage tissue engineering.
Cite this paper: Li, Z. , Zhang, Z. , Song, G. , Fu, S. , Jin, L. and Liu, Y. (2019) The Application Prospect Autologous Bone Marrow Extract Buffy Coat in Cartilage Tissue Engineering: A Mini-Review. Journal of Biosciences and Medicines, 7, 9-17. doi: 10.4236/jbm.2019.712002.

[1]   Dozin, B., Malpeli, M., Cancedda, R., Bruzzi, P., Calcagno, S., Molfetta, L., Priano, F., Kon, E. and Marcacci, M. (2005) Comparative Evaluation of Autologous Chondrocyte Implantation and Mosaicplasty: A Multicentered Randomized Clinical Trial. Clinical Journal of Sport Medicine, 15, 220-226.

[2]   Komárek, J., Valis, P., Repko, M., Chaloupka, R. and Krbec, M. (2010) Treatment of Deep Cartilage Defects of the Knee with Autologous Chondrocyte Transplantation: Long-Term Results. Acta Chirurgiae Orthopaedicae et Traumatologiae Cechoslovaca, 77, 291-295.

[3]   Hubka, K.M., Dahlin, R.L., Meretoja, V.V., Kasper, F.K. and Mikos, A.G. (2014) Enhancing Chondrogenic Phenotype for Cartilage Tissue Engineering: Monoculture and Coculture of Articular Chondrocytes and Mesenchymal Stem Cells. Tissue Engineering Part B: Reviews, 20, 641-654.

[4]   Yu, D.A., Han, J. and Kim, B.S. (2012) Stimulation of Chondrogenic Differentiation of Mesenchymal Stem Cells. International Journal of Stem Cells, 5, 16-22.

[5]   Vinatier, C. and Guicheux, J. (2016) Cartilage Tissue Engineering: From Biomaterials and Stem Cells to Osteoarthritis Treatments. Annals of Physical and Rehabilitation Medicine, 59, 139-144.

[6]   Vinatier, C., Bouffi, C., Merceron, C., Gordeladze, J., Brondello, J.M., Jorgensen, C., Weiss, P., Guicheux, J. and Noel, D. (2009) Cartilage Tissue Engineering: Towards a Biomaterial-Assisted Mesenchymal Stem Cell Therapy. Current Stem Cell Research & Therapy, 4, 318-329.

[7]   Ossendorf, C., Kaps, C., Kreuz, P.C., Burmester, G.R., Sittinger, M. and Erggelet, C. (2007) Treatment of Posttraumatic and Focal Osteoarthritic Cartilage Defects of the Knee with Autologous Polymer-Based Three-Dimensional Chondrocyte Grafts: 2-Year Clinical Results. Arthritis Research & Therapy, 9, R41.

[8]   Cherubino, P., Grassi, F.A., Bulgheroni, P. and Ronga, M. (2003) Autologous Chondrocyte Implantation Using a Bilayer Collagen Membrane: A Preliminary Report. Journal of Orthopaedic Surgery (Hong Kong), 11, 10-15.

[9]   Ochi, M., Uchio, Y., Kawasaki, K., Wakitani, S. and Iwasa, J. (2002) Transplantation of Cartilage like Tissue Made by Tissue Engineering in the Treatment of Cartilage Defects of the Knee. The Journal of Bone and Joint Surgery. British Volume, 84, 571-578.

[10]   Branly, T., Contentin, R., Desancé, M., Jacquel, T., Bertoni, L., Jacquet, S., Mallein-Gerin, F., Denoix, J.M., Audigié, F., Demoor, M. and Galéra, P. (2018) Improvement of the Chondrocyte-Specific Phenotype upon Equine Bone Marrow Mesenchymal Stem Cell Differentiation: Influence of Culture Time, Transforming Growth Factors and Type I Collagen siRNAs on the Differentiation Index. International Journal of Molecular Sciences, 19, pii: E435.

[11]   Bai, Z., Guo, X.H., Tang, C., Yue, S.T., Shi, L. and Qiang, B. (2018) Effects of Artesunate on the Expressions of Insulin-Like Growth Factor-1, Osteopontin and C-Telopeptides of Type II Collagen in a Rat Model of Osteoarthritis. Pharmacology, 101, 1-8.

[12]   Maehara, H., Sotome, S., Yoshii, T., Torigoe, I., Kawasaki, Y., Sugata, Y., Yuasa, M., Hirano, M., Mochizuki, N., Kikuchi, M., Shinomiya, K. and Okawa, A. (2010) Repair of Large Osteochondral Defects in Rabbits Using Porous Hydroxyapatite/Collagen (HAp/Col) and Fibroblast Growth Factor-2 (FGF-2). Journal of Orthopaedic Research, 28, 677-686.

[13]   Schmidt, M.B., Chen, E.H. and Lynch, S.E. (2006) A Review of the Effects of Insulin-Like Growth Factor and Platelet Derived Growth Factor on in Vivo Cartilage Healing and Repair. Osteoarthritis and Cartilage, 14, 403-412.

[14]   Minina, E., Kreschel, C., Naski, M.C., Ornitz, D.M. and Vortkamp, A. (2002) Interaction of FGF, Ihh/Pthlh, and BMP Signaling Integrates Chondrocyte Proliferation and Hypertrophic Differentiation. Developmental Cell, 3, 439-449.

[15]   Duprez, D., Bell, E.J., Richardson, M.K., Archer, C.W., Wolpert, L., Brickell, P.M. and Francis-West, P.H. (1996) Overexpression of BMP-2 and BMP-4 Alters the Size and Shape of Developing Skeletal Elements in the Chick Limb. Mechanisms of Development, 57, 145-157.

[16]   Mazor, M., Lespessailles, E., Coursier, R., Daniellou, R., Best, T.M. and Toumi, H. (2014) Mesenchymal Stem-Cell Potential in Cartilage Repair: An Update. Journal of Cellular and Molecular Medicine, 18, 2340-2350.

[17]   Wang, K., Li, J., Li, Z., Wang, B., Qin, Y., Zhang, N., Zhang, H., Su, X., Wang, Y. and Zhu, H. (2019) Chondrogenic Progenitor Cells Exhibit Superiority over Mesenchymal Stem Cells and Chondrocytes in Platelet-Rich Plasma Scaffold-Based Cartilage Regeneration. The American Journal of Sports Medicine, 47, 2200-2215.

[18]   Pietrzak, W.S. and Eppley, B.L. (2005) Platelet Rich Plasma: Biology and New Technology. Journal of Craniofacial Surgery, 16, 1043-1054.

[19]   Gaissmaier, C., Koh, J.L. and Weise, K. (2008) Growth and Differentiation Factors for Cartilage Healing and Repair. Injury, 39, S88-S96.

[20]   Zhu, Y., Yuan, M., Meng, H.Y., Wang, A.Y., Guo, Q.Y., Wang, Y. and Peng, J. (2013) Basic Science and Clinical Application of Platelet-Rich Plasma for Cartilage Defects and Osteoarthritis: A Review. Osteoarthritis Cartilage, 21, 1627-1637.

[21]   Xie, X., Zhang, C. and Tuan, R.S. (2014) Biology of Platelet-Rich Plasma and Its Clinical Application in Cartilage Repair. Arthritis Research & Therapy, 16, 204.

[22]   Cassano, J.M., Kennedy, J.G., Ross, K.A., Fraser, E.J., Goodale, M.B. and Fortier, L.A. (2016) Bone Marrow Concentrate and Platelet-Rich Plasma Differ in Cell Distribution and Interleukin 1 Receptor Antagonist Protein Concentration. Knee Surgery, Sports Traumatology, Arthroscopy, 26, 333-342.

[23]   Horn, P., Bork, S. and Wagner, W. (2011) Standardized Isolation of Human Mesenchymal Stromal Cells with Red Blood Cell Lysis. Methods in Molecular Biology, 698, 23-35.

[24]   Jin, L.H., Choi, B.H., Kim, Y.J., Park, S.R., Jin, C.Z. and Min, B.H. (2011) Implantation of Bone Marrow-Derived Buffy Coat Can Supplement Bone Marrow Stimulation for Articular Cartilage Repair. Osteoarthritis Cartilage, 19, 1440-1448.

[25]   Yoon, S.H., Shim, Y.S., Park, Y.H., Chung, J.K., Nam, J.H., Kim, M.O., et al. (2007) Complete Spinal Cord Injury Treatment Using Autologous Bone Marrow Cell Transplantation and Bone Marrow Stimulation with Granulocyte Macrophage-Colony Stimulating Factor: Phase I/II Clinical Trial. Stem Cells, 25, 2066-2073.

[26]   Jin, L.H., Zhang, Z.Y., Liu, Y.Q., Gurung, K., Jin, Y.J., He, Y.M., Jin, Y. and Jin, Z.H. (2018) Comparison of Chondrogenic Ability between Mesenchymal Stem Cells and Buffy Coat in Vitro. Journal of Biosciences and Medicines, 6, 86-94.